Savings through generic drug usage in the U.S., by age group share 2023

Published by
Matej Mikulic,
Sep 16, 2024

This statistic depicts the distribution of savings through generic drugs and biosimilars usage in the United States in 2023, by age group. In that year, more than one third of all these savings were made with medications for senior citizens aged 65 years or older.

Percentage of savings through generic drug usage in the United States in 2023, by age group

Age groupPercentage of savings
Older Adults (40-64 years) 44%
Seniors (above 65 years) 34%
Other (0-39 years) 22%
Showing entries 1 to 3 (3 entries in total)
Created with Highcharts 7.2.2
• Older Adults (40-64 years) 44%
• Seniors (above 65 years) 34%
• Other (0-39 years) 22%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2024

Region

United States

Survey time period

2023

Supplementary notes

The statistic also includes biosimilars. All values were calculated based on provided figures. All values were rounded.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
Generics and biosimilars
  • 43 page/s
  • English
  • pptx
  • Detailed references

Everything on "Generics and biosimilars" in one document: edited and divided into chapters, including detailed references.

Go to report
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Generics and biosimilars "

Other statistics that may interest you Generics and biosimilars

Global overview

5

Top companies

5

U.S. market

6

Patent expiration

3

Savings

7

Biosimilars

7

Further related statistics

16

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Generics and biosimilarsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDrug pricing in the U.S.
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.